semaglutide lawsuit compounding Novo Nordisk expands legal action to protect US patients from unsafe, non-FDA-approved compounded "semaglutide" FDA Warns on Certain Forms

Women with diabetes who used GLP-1 agonists saw an even greater risk reduction compared with those who used insulin or metformin, but there was no significant difference when comparing GLP-1 meds and SGLT2 inhibitors

At Kalos, your journey continues after you reach your goal weightbecause we understand that significant weight loss changes your body in ways that go beyond the number you see

Its GLP-1, GIP, and glucagon triple-agonist design makes it an important compound for studying dose-sensitive and early-stage metabolic regulation mechanisms.

Tracy Beth Hoeg, who, according to various news outlets, has criticized the use of COVID-19 vaccines in children and young adults and has advocated for paring down the recommended schedule for childhood vaccinations, was appointed acting director of CDER on Wednesday

Doublecortin is preferentially expressed in invasive human brain tumors